Home
About us
Our history
President’s word
Philosophy
Therapy
Expertise and know-how
Teams
Pathologies
Mitral valve regurgitation
Urinary incontinence
Our activities
Kalios™
Epygon
Artus
Kardiozis
Join us
News
Investors
2024 titre
by
Webdesign Squad
|
Oct 27, 2023
ok pour 2024
2023 titre
by
Webdesign Squad
|
Oct 27, 2023
ok pour 2023
Search for:
Recent Posts
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO
Interview with Dr. Sarraf
Epygon: A unique device for mitral valve repair
Interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, in the “Actu Bourse” issue on Boursorama
Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
Spécialiste produit – Urologie
Recent Comments
Recent Comments